7AI
7AI is a startup headquartered in Boston, United States, founded in 2023. It has raised at least $166.7m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
7AI has raised at least $166.7m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
7AI sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Boston
- 123 See
- Acta Pharmaceuticals
- Acumino
- AdvocateMH
- AI Proteins
- Amplitude Vascular Systems
- Animerra
- Anna Health
- Antares Therapeutics
- Appex Group
- Atalan Tech
Related
- Innovation profile of Boston
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does 7AI do?
7AI is classed in technology in its filings with the US Securities and Exchange Commission.
How much has 7AI raised?
At least $166.7m, according to its Form D filings with the US Securities and Exchange Commission.
Where is 7AI based?
7AI is headquartered in Boston, United States.
When was 7AI founded?
7AI was founded in 2023.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.